The Tuberculosis treatment success rate for newly treated cases in the US shows a gradual decline from 74% in 2024 to 72% in 2028, indicating a slight negative trend. This trend suggests a year-on-year decrease and an overall negative CAGR, reflecting challenges in improving treatment outcomes over the forecast period. As of 2023, the success rate stood at 75%, which shows a slight decline over the ensuing years to 2028.

Future trends to watch for include:

The impact of new treatments and technologies that could potentially improve success rates.
Public health strategies and policies designed to enhance patient adherence and treatment access.
The effect of socioeconomic factors and healthcare infrastructure on treatment success.